Haleon (HLNCF) FCF Payout Ratio (2021 - 2023)

Haleon (HLNCF) recorded quarterly FCF Payout Ratio of 1.82 in Q4 2023, up 83.74% on a QoQ basis from 11.19 in Q4 2022, and up 83.74% year-over-year from 0.99 in Q4 2022.

Haleon (HLNCF) FCF Payout Ratio (2021 - 2023) Analysis & Trends

Haleon has disclosed FCF Payout Ratio across 3 years of filings, most recently posting 1.82 for Q4 2023.

  • Quarterly FCF Payout Ratio rose 83.74% year-over-year to 1.82 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 13.22 (changed N/A YoY) and the FY2025 annual result came in at 0.26, up 587.23% from the prior year.
  • FCF Payout Ratio advanced to 1.82 in Q4 2023, from 11.19 in the prior quarter.
  • Over five years, FCF Payout Ratio peaked at 1.82 in Q4 2023 and troughed at 11.19 in Q3 2022.
  • A 3-year average of 7.8 and a median of 9.08 in 2022 frame the typical range for FCF Payout Ratio.
  • Annual changes were most pronounced in 2022 — FCF Payout Ratio tumbled 60.41% — and 2023, when it surged 83.74%.
  • Tracing HLNCF's FCF Payout Ratio over 3 years: stood at 6.98 in 2021, then slumped by 60.41% to 11.19 in 2022, then jumped by 83.74% to 1.82 in 2023.
  • Business Quant data shows HLNCF's FCF Payout Ratio at 1.82 in Q4 2023, 11.19 in Q4 2022, and 11.19 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 0.77
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Haleon - - - -

Historic Data

Download Data
DateValue
Dec 31, 2023 -1.82
Dec 31, 2022 -11.19
Sep 20, 2022 -11.19
Dec 31, 2021 -6.98